Please login to the form below

Aspen

This page shows the latest Aspen news and features for those working in and with pharma, biotech and healthcare.

Grünenthal buys Zomig rights as AZ slimming drive continues

This work has seen it agree deals with TerSera Therapeutics ($320m for Zoladex), ProStakan ($70m for Moventig), Aspen ($770m for seven anaesthetics drugs) and, most recently, Recordati ($300m for two blood

Latest news

EU starts investigation of Aspen's cancer drug pricing

EU starts investigation of Aspen's cancer drug pricing. Amid reports of price increases of several hundred per cent. ... Aspen Pharmacare is under investigation by the EU's competition authorities over its pricing of five cancer medicines, amid
Italian pharma scandals prompts call for EU-wide pricing probe

Italian pharma scandals prompts call for EU-wide pricing probe. Aspen fined 5.2m for threat to halt supply of cancer drugs if price hikes not accepted. ... The negotiation strategy adopted by Aspen was so aggressive as to reach the credible threat of
AstraZeneca sells rights to seven anaesthetics in $770m deal

AstraZeneca sells rights to seven anaesthetics in $770m deal. Ten-year agreement with Aspen continues the streamlining of its operations. ... AstraZeneca has divested seven drugs from its anaesthetics portfolio through a $770m deal with Aspen Global
Endo buys Par for $8bn as M&A mania marches on

All told Endo has already spent around $10bn on M&A in recent months, closing a generics deal with South Africa's Aspen Holdings earlier this month.
GSK sells another chunk of South Africa's Aspen

GSK sells another chunk of South Africa's Aspen. Paid $418m for an 18% share in Aspen in 2009. ... We continue to believe in the strategy of Aspen and we remain committed to working together in the future," said Dingemans.

More from news
Approximately 7 fully matching, plus 22 partially matching documents found.

Latest Intelligence

Deal Watch October 2016

$330m. Neurology 2016. Aspen. 5 anesthetics. $770m royalties. $592m. 1.3. Neurology 2014.
Deal Watch September 2016

Reflecting a long standing business relationship, Aspen paid GSK £180m to acquire Ultiva, Nimbex, Tracrium, Mivacron and Anectinein, plus up to £100m in milestone payments. ... 500. GSK / Aspen. Asset acquisition. Sale of anaesthetic drugs [Ultiva,
Deal Watch June 2016

Meanwhile AstraZeneca has out-licensed ex-US rights to a portfolio of seven anaesthetics to Aspen. ... Paying $520m upfront Aspen gains access to a series of local anaesthetics including Marcaine (bupivacaine) and Xylocaine (lidocaine/ lignocaine), and
Pharma deals in May 2015

360. Aspen/ Strides Arcolab. Divestment. Range of branded and generic drugs.
Deal Watch table for January 2015

Licence, option and collaboration. 164. Novartis/Aspen. Purchase of the heparin based anticoagulant Mono-Embolex, with sales of 68m in 2013.

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

Competition from within

Teva (Israel), CSL (Australia) and Aspen (South Africa) are notable exceptions, with the Indian generic giants Sun and Ranbaxy - which have since merged - the only representation from the ‘ BRIC’ markets (Brazil,
Compliance Hub Ltd

Address:. Aspen Farm. Sheep Lane Woburn. Bedfordshire. MK17 9HD. UK.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Senior Medical Writer: Competitive Salary

Consultant Health Economics - London / Oxford: Negotiable

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Senior Account Executive, London, Medical Communications: Excellent package

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Scientific Director / Editorial Team Leader: Great salary and benefits

Project / Account Manager (Medical Education): Salary TBC

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

Consumer Health Account Director: Circa £60, 000 Gym and More

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Senior Medical Writer: Great salary and benefits

Associate Medical Director: Highly Competitive

Senior Account Director development role to Business Director, H...: Excellent package

Medical Writers: Competitive Salary and Benefits

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Associate Director: £75, 000-90, 000

Account Director: Excellent benefits

Associate Editorial Director – Med Comms – London: Salary TBC

Events Manager – Med Comms – Surrey: Salary TBC

Director, Market Access / HEOR - North-West: Negotiable

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Senior Systematic Review Analyst - Oxford: Negotiable

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Subscribe to our email news alerts

PMHub

Add my company

Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Innovation in merger control and the impact on the pharmaceutical sector: Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think: Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Quality in Care Diabetes 2018: the best in innovative diabetes care: Awards highlight new evidence-based approaches to improving care...